The slowdown in elective procedures and reduced demand for costly drugs

Updated May 7, 2013- The demand for prescription drugs and medical devices is continuing to slow down, as new forms of employer-provided health insurance require greater out-of-pocket expenses for costly drugs or procedures. After the first quarter of earnings, almost all drug companies reported slower than expected sales. The Healthcare Channel was the first to bring up this issue back in 2010.

October 29, 2010

In Part 5 of the Weekly Summary show, Frank Eismont, MD, Chairman of The Department of Orthopaedics at The University of Miami Miller School of Medicine, leads the roundtable discussion on the slowdown in elective procedures such as orthopedic implants and spine fusion caused by the high unemployment and fewer insured. The same factors are also causing reductions in what would seem to be non-elective therapies, such as branded diabetes drugs and coronary stenting.

This entry was posted in CMS, Congress. Bookmark the permalink.

Leave a Reply

Your email address will not be published.